| 硼替佐米联合柔红霉素、阿糖胞苷诱导并联合中剂量阿糖胞苷巩固治疗初治老年AML患者的研究 |
| |
| 引用本文： | 江滨,廖鹏军.硼替佐米联合柔红霉素、阿糖胞苷诱导并联合中剂量阿糖胞苷巩固治疗初治老年AML患者的研究[J].循证医学,2013,13(5):268-270. |
| |
| 作者姓名： | 江滨 廖鹏军 |
| |
| 作者单位： | 1. 北京大学人民医院血液病研究所血液科, 北京100044;br/> 2. 广东省人民医院肿瘤中心血液科、广东省医学科学院, 广州510080 |
| |
| 摘 要： | 1文献来源
Attar EC, Johnson JL, Amrein PC, et al. Bortezomib added to Daunorubicin and Cytarabine during induction therapy and to intermediate-dose Cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years： CALGB （Alliance） study 10502 J]. J Clin Oncol, 2013,31（7） ：923-929.
|
| 关 键 词： | 初治老年急性髓性白血病 硼替佐米 诱导治疗 巩固 |
Bortezomib Added to Daunorubicin and Cytarabine during Induction Therapy and to Intermediate-Dose Cytarabine for Consolidation in Patients with Previously Untreated Acute Myeloid Leukemia Age 60 to 75 Years |
| |
| JIANG Bin,LIAO Peng-jun.Bortezomib Added to Daunorubicin and Cytarabine during Induction Therapy and to Intermediate-Dose Cytarabine for Consolidation in Patients with Previously Untreated Acute Myeloid Leukemia Age 60 to 75 Years[J].The Journal of Evidence-Based Medicine,2013,13(5):268-270. |
| |
| Authors: | JIANG Bin LIAO Peng-jun |
| |
| Institution: | Reviewer’s address： Department of Hematology, Peking Institute of Hematology, Peking University People＇s Hospital,Beijing 100044, China |
| |
| Abstract: | previously untreated elderly adults acute myeloidleukemia Bortezomib induction therapy consolidation |
| |
| Keywords: | previously untreated elderly adults acute myeloidleukemia Bortezomib induction therapy consolidation |
| 本文献已被 维普 等数据库收录！ |
| 点击此处可从《循证医学》浏览原始摘要信息 |
| 点击此处可从《循证医学》下载免费的PDF全文 |
